查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873242

全球内视镜黏膜切除术技术市场

Endoscopic Mucosal Resection Technology
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球内视镜黏膜切除术技术市场预计到2030年将达到57亿美元。

2024年全球内视镜黏膜切除术市场规模估计为37亿美元，预计到2030年将达57亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为7.6%。本报告分析的细分市场之一－提拉切开术，预计复合年增长率为6.6%，到分析期末将达到30亿美元。囊袋切开术细分市场预计在分析期间内复合年增长率为8.8%。

美国市场规模估计为10亿美元，而中国市场预计将以7.1%的复合年增长率成长。

据估计，到2024年，美国内视镜黏膜切除术（EMR）技术市场规模将达10亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到8.779亿美元，2024年至2030年的复合年增长率（CAGR）为7.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到6.8%和6.2%。在欧洲，德国的复合年增长率预计将达到约6.4%。

全球内视镜黏膜切除术技术市场—主要趋势与驱动因素概述

内视镜黏膜切除术技术如何革新胃肠道癌症的治疗？

内视镜黏膜切除术(EMR) 技术正在革新胃肠道癌症的治疗，它为切除胃肠道癌前病变和早期癌症提供了一种微创且高效的选择。 EMR 在治疗食道癌、胃癌和大肠直肠癌等疾病方面尤其重要，因为早期发现并切除异常组织可以防止病情发展至晚期。此技术使用内视镜（配备摄影机和器械的软管）切除胃肠道黏膜层，无需传统手术即可去除异常组织。 EMR 不仅降低了开放性手术的风险和缩短了恢復时间，还能保护胃肠道的结构，维持病患的正常功能和生活品质。随着人们对胃肠道癌症的认识不断提高以及筛检的普及，EMR 已成为一种早期、微创的癌症治疗治疗方法，有望显着改善患者的预后。

哪些创新正在增强内视镜黏膜切除术（EMR）技术的功能？

内视镜黏膜切除术(EMR) 技术的创新正透过影像、切除和辅助性治疗的进步不断提升其功能。其中一项最重要的进展是将高清影像与先进的内视镜技术相结合，例如窄频成像 (NBI) 和染色内视镜。这使得异常组织的辨识和界定更加精准，使胃肠病学家能够发现以往容易被忽略的微小病变。这提高了切除术的有效性和安全性。另一项关键创新是混合 EMR 技术的开发，该技术将传统切除术与黏膜下注射和使用专用切除器械等其他技术相结合。这使得更大、更复杂的病变能够被完整且可控地切除，最大限度地降低了切除不完全和復发的风险，并提高了手术的长期成功率。此外，将内视镜黏膜下切除术（EMR）与射频消融术（RFA）和冷冻疗法等辅助性治疗结合，扩大了其适用病灶的范围，并改善了疑难病例的治疗效果。这些创新使EMR更加有效、安全且易于实施，巩固了其作为胃肠道肿瘤早期治疗重要手段的地位。

内视镜黏膜切除术（EMR）如何影响患者的治疗结果与治疗选择？

内视镜黏膜切除术(EMR) 为早期胃肠道癌症和癌前病变的切除提供了一种微创但高效的替代传统手术的方法，显着改善了患者的预后和治疗选择。与创伤较大的治疗方法手术相比，EMR 可使患者更快康復，术后疼痛更轻，且併发症风险更低。该技术的另一个主要优势在于能够维持胃肠道的完整性，使患者无需进行广泛的切除或重组手术即可维持正常的消化功能。这对于治疗巴瑞特氏食道症和早期大肠直肠癌等疾病尤其重要，因为这些疾病的治疗目标是在切除异常组织的同时，最大限度地减少对患者生活品质的影响。此外，EMR 也为因年龄、合併症或病变位置等原因不适合手术的患者提供了新的治疗选择。内视镜黏膜切除术（EMR）是一种微创手术，可在门诊进行，因此能够减轻医疗资源的负担，并为更多患者提供可行的治疗选择。 EMR 对早期癌症的有效治疗也有助于改善患者的长期预后。由于早期疗育对于预防癌症进展和提高存活率至关重要，EMR 正在改变胃肠道癌症和癌前病变的治疗方式，成为一种兼顾疗效、患者舒适度和安全性的治疗选择。

哪些趋势正在推动内视镜黏膜切除术（EMR）技术市场的成长？

推动内视镜黏膜切除术(EMR) 技术市场成长的关键趋势包括：对早期癌症检测的日益重视、内视镜技术的进步以及对微创手术需求的不断增长。人们越来越意识到早期检测在成功治疗胃肠道癌症的重要性，这促使大肠镜检查和上消化道内视镜检查等筛检项目广泛应用。随着越来越多的病变和早期癌症被发现，对有效、微创治疗方法（例如 EMR）的需求也在不断增长。内视镜技术的进步，例如影像技术的改进、精密仪器的开发以及混合技术的出现，也扩大了 EMR 的应用范围，使其适用于更广泛的患者群体和病变类型。患者和医疗服务提供者都希望获得恢復时间更短、併发症更少、整体成本更低的治疗方法方法，这推动了微创手术的普及，也是市场成长的关键因素。此外，与内视镜黏膜下剥离术 (ESD) 和消融疗法等新兴疗法的融合，也进一步拓展了 EMR 的应用范围和市场吸引力。胃肠道疾病的日益普遍以及人口老化（老年人更容易患上这些疾病）进一步推动了市场成长。这些趋势支持了EMR技术在现代胃肠肿瘤学中日益重要的作用，EMR技术仍然是有效治疗早期癌症和癌前病变的重要且微创的选择。

部分：

依手术技术（提起和切除、囊状切除）、适应症（食道癌、十二指肠癌、胃癌、结肠癌）和最终用途（医院、门诊手术中心、其他最终用途）分类

受访公司范例

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech（Nanjing）Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对不同地区市场的影响。全球产业分析师预测，企业的竞争地位将根据其总部所在地、製造地以及进出口状况（成品和OEM产品）而有所变化。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP11787

Global Endoscopic Mucosal Resection Technology Market to Reach US$5.7 Billion by 2030

The global market for Endoscopic Mucosal Resection Technology estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Lift-and-Cut Technique, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Suck-and-Cut Technique segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 7.1% CAGR

The Endoscopic Mucosal Resection Technology market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$877.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Endoscopic Mucosal Resection Technology Market - Key Trends and Drivers Summarized

How Is Endoscopic Mucosal Resection Technology Revolutionizing Gastrointestinal Cancer Treatment?

Endoscopic Mucosal Resection (EMR) technology is revolutionizing gastrointestinal cancer treatment by offering a minimally invasive, highly effective option for removing precancerous lesions and early-stage cancers from the digestive tract. EMR is particularly valuable in treating conditions such as esophageal, gastric, and colorectal cancers, where early detection and removal of abnormal tissues can prevent the progression to more advanced disease stages. This technique involves the use of an endoscope-a flexible tube equipped with a camera and instruments-to resect the mucosal layer of the gastrointestinal tract, removing the abnormal tissue without the need for traditional surgery. EMR not only reduces the risks and recovery times associated with open surgery but also preserves the integrity of the gastrointestinal tract, maintaining normal function and quality of life for patients. As awareness and screening for gastrointestinal cancers increase, EMR is becoming a preferred treatment option, transforming the landscape of cancer care by enabling early, less invasive interventions that can significantly improve patient outcomes.

What Innovations Are Enhancing the Functionality of Endoscopic Mucosal Resection Technology?

Innovations in Endoscopic Mucosal Resection (EMR) technology are enhancing its functionality through advancements in imaging, resection techniques, and adjunctive therapies. One of the most significant developments is the integration of high-definition imaging and advanced endoscopic technologies, such as narrow-band imaging (NBI) and chromoendoscopy, which allow for more precise identification and delineation of abnormal tissues. These imaging techniques enable gastroenterologists to detect even subtle lesions that might otherwise be missed, increasing the effectiveness and safety of the resection. Another key innovation is the development of hybrid EMR techniques that combine traditional resection with additional methods, such as submucosal injection or the use of specialized resection devices, to achieve more complete and controlled removal of larger or more complex lesions. This approach minimizes the risk of incomplete resection and recurrence, enhancing the long-term success of the procedure. Additionally, the combination of EMR with adjunctive therapies, such as radiofrequency ablation (RFA) or cryotherapy, is expanding its applicability to a broader range of lesions and improving outcomes for patients with more challenging cases. These innovations are making EMR more effective, safer, and accessible, solidifying its role as a critical tool in the early treatment of gastrointestinal cancers.

How Does Endoscopic Mucosal Resection Impact Patient Outcomes and Treatment Options?

Endoscopic Mucosal Resection (EMR) has a profound impact on patient outcomes and treatment options by providing a less invasive, yet highly effective alternative to traditional surgery for the removal of early-stage cancers and precancerous lesions in the gastrointestinal tract. For patients, EMR offers the potential for a quicker recovery, less postoperative pain, and a lower risk of complications compared to more invasive surgical procedures. The preservation of the gastrointestinal tract’s integrity is another significant benefit, as it allows patients to maintain normal digestive functions without the need for extensive resection or reconstruction. This is particularly important in the treatment of conditions like Barrett’s esophagus or early-stage colorectal cancer, where the goal is to remove the abnormal tissue while minimizing the impact on the patient’s quality of life. Additionally, EMR expands treatment options for patients who may not be suitable candidates for surgery due to age, comorbidities, or the location of the lesion. By offering a minimally invasive option that can be performed on an outpatient basis, EMR reduces the burden on healthcare resources and provides a viable alternative for a broader range of patients. The ability to effectively treat early-stage cancers with EMR also contributes to better long-term outcomes, as early intervention is key to preventing the progression of cancer and improving survival rates. By providing a treatment option that balances effectiveness with patient comfort and safety, EMR is transforming the management of gastrointestinal cancers and precancerous conditions.

What Trends Are Driving Growth in the Endoscopic Mucosal Resection Technology Market?

Several trends are driving growth in the Endoscopic Mucosal Resection (EMR) technology market, including the increasing emphasis on early cancer detection, advancements in endoscopic technology, and the rising demand for minimally invasive procedures. The growing awareness of the importance of early detection in the successful treatment of gastrointestinal cancers is leading to more widespread use of screening programs such as colonoscopy and upper endoscopy. As more lesions and early-stage cancers are identified, the demand for effective, minimally invasive treatment options like EMR is increasing. Advancements in endoscopic technology, including improvements in imaging, precision instrumentation, and hybrid techniques, are also expanding the capabilities of EMR, making it suitable for a wider range of patients and lesions. The shift towards minimally invasive procedures is another significant driver, as both patients and healthcare providers seek treatments that offer reduced recovery times, fewer complications, and lower overall costs. Additionally, the integration of EMR with other emerging therapies, such as endoscopic submucosal dissection (ESD) and ablative techniques, is broadening its application and appeal. The increasing prevalence of gastrointestinal conditions, coupled with an aging population that is more susceptible to these diseases, is further fueling market growth. These trends underscore the expanding role of EMR technology in modern gastrointestinal oncology, as it continues to provide a critical, less invasive option for the effective treatment of early-stage cancers and precancerous conditions.

SCOPE OF STUDY:

The report analyzes the Endoscopic Mucosal Resection Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Lift-and-Cut Technique, Suck-and-Cut Technique); Indication (Esophageal Cancer, Duodenal Cancer, Stomach Cancer, Colon Cancer); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech (Nanjing) Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Endoscopic Mucosal Resection Technology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Gastrointestinal Diseases Fueling Adoption of EMR Technology
    • Rising Demand for Minimally Invasive Surgeries in Gastroenterology
    • Integration of Digital Imaging and AI to Assist in Precise Lesion Targeting
    • Patient Preference for Procedures with Faster Recovery Times Driving EMR Utilization
    • Global Expansion of Healthcare Infrastructure Supporting Advanced Endoscopic Methods
    • Economic Analysis of Cost-Effectiveness and Benefits of EMR Over Traditional Surgeries
    • Advancements in Sedation and Pain Management for Endoscopic Procedures
    • Research Initiatives to Improve Polyp Detection and Removal Techniques
    • Future Trends in Robotic Assistance for Endoscopic Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lift-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Suck-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Stomach Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Duodenal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Endoscopic Mucosal Resection Technology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Endoscopic Mucosal Resection Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION